Cite
Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy.
MLA
Lee, Se‐Hoon, et al. “Sunitinib in Metastatic Renal Cell Carcinoma: An Ethnic Asian Subpopulation Analysis for Safety and Efficacy.” Asia Pacific Journal of Clinical Oncology, vol. 10, no. 3, Sept. 2014, pp. 237–45. EBSCOhost, https://doi.org/10.1111/ajco.12163.
APA
Lee, S., Bang, Y., Mainwaring, P., Ng, C., Chang, J. W., Kwong, P., Li, R. K., Sriuranpong, V., Toh, C., Yuan, J., Pitman Lowenthal, S., & Chung, H. C. (2014). Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy. Asia Pacific Journal of Clinical Oncology, 10(3), 237–245. https://doi.org/10.1111/ajco.12163
Chicago
Lee, Se‐Hoon, Yung‐Jue Bang, Paul Mainwaring, Christina Ng, John W‐C Chang, Philip Kwong, Rubi K Li, et al. 2014. “Sunitinib in Metastatic Renal Cell Carcinoma: An Ethnic Asian Subpopulation Analysis for Safety and Efficacy.” Asia Pacific Journal of Clinical Oncology 10 (3): 237–45. doi:10.1111/ajco.12163.